Feature Avalo Therapeutics Stock Is Down -7.8% After Missing EPS EstimateBy James WilliamFebruary 8, 2024 EPS Estimate Avalo Therapeutics missed their EPS estimate and fell hasty concerning revenue, according to the companys most recent quarterly…
